Erythropoietin in kidney disease and type 2 diabetes.
Peter
P
Schnuelle
Urs
U
Benck
Bernhard K
BK
Krämer
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002318:Cardiovascular Diseases / Q000453:epidemiology; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005293:Ferritins / Q000097:blood; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000401:mortality; D012306:Risk
D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D005293:Ferritins; D007501:Iron